E.e.s. and Atrovent drug interactions - a phase IV clinical study of FDA data
Summary:
We study 33,306 people who take E.e.s. (erythromycin ethylsuccinate) and Atrovent (ipratropium bromide). There is no drug interaction reported.
The study analyzes what interactions people have when they take E.e.s. and Atrovent. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
What is E.e.s.?
E.e.s. has active ingredients of erythromycin ethylsuccinate. eHealthMe is studying from 96 E.e.s. users. Check the latest studies of E.e.s..
What is Atrovent?
Atrovent has active ingredients of ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 33,210 Atrovent users. Check the latest studies of Atrovent.
No report is found.
Do you take E.e.s. and Atrovent?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
How the study uses the data?
The study uses data from the FDA. It is based on erythromycin ethylsuccinate and ipratropium bromide (the active ingredients of E.e.s. and Atrovent, respectively), and E.e.s. and Atrovent (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Celexa cause Hypotonia? - 13 seconds ago
- How effective is Toprol-Xl for High Blood Pressure? - 14 seconds ago
- Dry Skin and Hypokalemia - 26 seconds ago
- Could Pentasa cause Hypertension Aggravated? - 28 seconds ago
- Drug interactions of Quetiapine Fumarate and Formoterol Fumarate - 29 seconds ago
- Could Ursodiol cause Hypertension Aggravated? - 37 seconds ago
- Could Stelara cause Appetite Decreased? - 40 seconds ago
- Could Stelara cause Appetite - Decreased? - 40 seconds ago
- Could Maxalt cause Hypertension Aggravated? - 47 seconds ago
- Drug interactions of Glycine and Calcitriol - 49 seconds ago